Revolution Medicines, Inc. (RVMD) Operating cash flow 2018–2025
Revolution Medicines, Inc. (RVMD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$897.7MFY2025 · since FY2018: $1.2M → -$897.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$897.7M | -61.0% |
| FY2024 | -$557.4M | -59.0% |
| FY2023 | -$350.6M | -56.2% |
| FY2022 | -$224.4M | -52.5% |
| FY2021 | -$147.2M | -47.1% |
| FY2020 | -$100.1M | -101.7% |
| FY2019 | -$49.6M | -4190.4% |
| FY2018 | $1.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RVMD financial trends
RVMD RevenueRVMD Net incomeRVMD Net marginRVMD Gross profitRVMD Gross marginRVMD Operating incomeRVMD Operating marginRVMD Free cash flowRVMD Capital expendituresRVMD Return on equityRVMD Stock buybacksRVMD Dividends paidRVMD Total assetsRVMD Total liabilitiesRVMD Shareholders’ equityRVMD overview →